08:00 , Feb 18, 2013 |  BC Week In Review  |  Company News

Albany Molecular Research, Bessor Pharma deal

Translational drug development company Bessor exercised a 2012 option from contract research and manufacturing services company AMRI to license exclusive, worldwide rights to IP related to cancer compound ALB 109564(a) . Bessor formed its affiliate...
07:00 , Apr 9, 2012 |  BC Week In Review  |  Company News

Albany Molecular Research, Bessor Pharma deal

Contract research and manufacturing services company Albany Molecular granted translational drug development company Bessor an eight-month option to license exclusive, worldwide rights to IP related to its cancer compound ALB 109564(a) . Albany Molecular will...